HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Karl Selected Research

Alexander Karl Research Topics

Disease

25Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 08/2005
18Neoplasms (Cancer)
10/2023 - 11/2007
8Carcinoma (Carcinomatosis)
01/2024 - 11/2007
6Non-Muscle Invasive Bladder Neoplasms
10/2020 - 11/2013
5Prostatic Neoplasms (Prostate Cancer)
10/2017 - 08/2008
5Renal Cell Carcinoma (Grawitz Tumor)
03/2015 - 09/2008
4Neoplasm Metastasis (Metastasis)
10/2017 - 11/2007
4Margins of Excision
07/2016 - 08/2008
2Inflammation (Inflammations)
07/2021 - 06/2003
2Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 08/2015
2Lymphatic Metastasis
04/2009 - 11/2007
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2009 - 04/2007
1Gout
04/2022
1Thrombocytosis (Thrombocythemia)
01/2020
1Acidosis
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Flatulence
11/2018
1Convalescence
11/2018
1Carcinoma in Situ
05/2018
1Papillary Carcinoma
05/2018
1Pain (Aches)
08/2017
1Critical Illness (Critically Ill)
08/2015
1Renal Insufficiency (Renal Failure)
08/2015
1Acute Kidney Injury (Acute Renal Failure)
08/2015
1Chronic Renal Insufficiency
03/2015
1Intraoperative Complications
01/2014
1Spinal Cord Diseases
09/2011
1Stress Urinary Incontinence
07/2011
1Malnutrition (Nutritional Deficiencies)
05/2009
1Neoplasm Micrometastasis
04/2009
1Necrosis
03/2009
1Lower Urinary Tract Symptoms
03/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2007
1Penile Neoplasms (Penile Cancer)
11/2007
1Transitional Cell Carcinoma
02/2007
1Muscle Cramp (Cramp)
06/2003
1Wounds and Injuries (Trauma)
06/2003

Drug/Important Bio-Agent (IBA)

55-aminolevulinic acid hexyl esterFDA Link
10/2017 - 11/2010
3AcidsIBA
08/2008 - 08/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2022
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2022
1Antihypertensive Agents (Antihypertensives)IBA
04/2022
1Angiotensin Receptor AntagonistsIBA
04/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1LigandsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
07/2021
1Mitogen-Activated Protein KinasesIBA
05/2021
1Therapeutic UsesIBA
05/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1BiglycanIBA
01/2019
1Proteoglycans (Proteoglycan)IBA
01/2019
1Phenobarbital (Luminal)FDA Link
05/2018
1Lipocalin-2IBA
01/2018
1Cystatin CIBA
01/2018
1gallium 68 PSMA-11IBA
10/2017
1Hemoglobins (Hemoglobin)IBA
04/2017
1Human Serum AlbuminFDA LinkGeneric
08/2015
1Starch (Cornstarch)IBA
08/2015
1CreatinineIBA
03/2015
1DNA (Deoxyribonucleic Acid)IBA
03/2014
1Trypsin InhibitorsIBA
03/2014
1SuspensionsIBA
07/2011
11-dodecylpyridoxal (PLD)IBA
12/2010
1Prostate-Specific Antigen (Semenogelase)IBA
07/2010
1AndrogensIBA
01/2009
1Sunitinib (Sutent)FDA Link
01/2009
1squamous cell carcinoma-related antigenIBA
11/2007
1nuclear matrix protein 22IBA
02/2007
1EstersIBA
08/2005
1Photosensitizing Agents (Photosensitizers)IBA
08/2005
1hypericinIBA
08/2005
1Antimicrobial PeptidesIBA
06/2003

Therapy/Procedure

16Cystectomy
01/2024 - 04/2009
8Prostatectomy (Retropubic Prostatectomy)
10/2017 - 04/2007
7Therapeutics
05/2021 - 01/2009
4Lymph Node Excision (Lymph Node Dissection)
10/2017 - 04/2009
3Transurethral Resection of Bladder
10/2020 - 11/2014
2Drug Therapy (Chemotherapy)
10/2023 - 04/2022
2Urinary Diversion (Ileal Conduit)
01/2022 - 01/2020
2Blood Transfusion (Blood Transfusions)
01/2020 - 04/2017
2Length of Stay
11/2018 - 08/2015
2Nephroureterectomy
10/2013 - 09/2008
2Nephrectomy
08/2009 - 09/2008
1Neoadjuvant Therapy
01/2022
1Enhanced Recovery After Surgery
01/2020
1Critical Care (Surgical Intensive Care)
08/2017
1Adjuvant Radiotherapy
07/2016
1Radiotherapy
07/2016
1Immunotherapy
10/2015
1Renal Dialysis (Hemodialysis)
03/2015
1Operative Time
01/2014
1Suburethral Slings (Tension-Free Vaginal Tape)
07/2011
1Immunomodulation
03/2010
1Nutrition Therapy (Medical Nutrition Therapy)
05/2009
1Semiconductor Lasers
03/2009
1Contraindications
01/2009
1Palliative Care (Palliative Therapy)
01/2009
1Adjuvant Chemotherapy
01/2009
1Solid-State Lasers
04/2007